# FDA Inspection 1238380 - Livzon Group Fuzhou Fuxing Pharmaceutical Co., Ltd. - April 05, 2024

Source: https://www.keypedia.com/records/fda_inspections/livzon-group-fuzhou-fuxing-pharmaceutical-co-ltd/e0696e30-41f8-4536-8a02-19a3b70905dc
Source feed: FDA_Inspections

> FDA Inspection 1238380 for Livzon Group Fuzhou Fuxing Pharmaceutical Co., Ltd. on April 05, 2024. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1238380
- Company Name: Livzon Group Fuzhou Fuxing Pharmaceutical Co., Ltd.
- Inspection Date: 2024-04-05
- Classification: No Action Indicated (NAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1063706 - 2018-08-03](https://www.keypedia.com/records/fda_inspections/livzon-group-fuzhou-fuxing-pharmaceutical-co-ltd/22c101b0-0313-4d17-9552-3c19288bdec6)
- [FDA Inspection 921555 - 2015-03-20](https://www.keypedia.com/records/fda_inspections/livzon-group-fuzhou-fuxing-pharmaceutical-co-ltd/407be2f2-874c-4784-8b66-4a5794936ae8)
- [FDA Inspection 754956 - 2011-11-11](https://www.keypedia.com/records/fda_inspections/livzon-group-fuzhou-fuxing-pharmaceutical-co-ltd/7140eb68-00cb-4c39-82e9-ae91b3542d6b)

Company: https://www.keypedia.com/companies/livzon-group-fuzhou-fuxing-pharmaceutical-co-ltd/85d625ce-81a2-4945-95fa-06bfae9e1532

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c